- Home
- POCI vs ICCC Comparison
POCI vs ICCC Comparison
Compare POCI & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POCI
- ICCC
- Stock Information
- Founded
- POCI 1982
- ICCC 1982
- Country
- POCI United States
- ICCC United States
- Employees
- POCI N/A
- ICCC N/A
- Industry
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- POCI Health Care
- ICCC Health Care
- Exchange
- POCI Nasdaq
- ICCC Nasdaq
- Market Cap
- POCI 34.4M
- ICCC 39.2M
- IPO Year
- POCI N/A
- ICCC 1987
- Fundamental
- Price
- POCI $4.10
- ICCC $4.97
- Analyst Decision
- POCI
- ICCC
- Analyst Count
- POCI 0
- ICCC 0
- Target Price
- POCI N/A
- ICCC N/A
- AVG Volume (30 Days)
- POCI 14.6K
- ICCC 11.2K
- Earning Date
- POCI 05-14-2025
- ICCC 05-13-2025
- Dividend Yield
- POCI N/A
- ICCC N/A
- EPS Growth
- POCI N/A
- ICCC N/A
- EPS
- POCI N/A
- ICCC N/A
- Revenue
- POCI $18,682,766.00
- ICCC $26,493,000.00
- Revenue This Year
- POCI N/A
- ICCC N/A
- Revenue Next Year
- POCI N/A
- ICCC N/A
- P/E Ratio
- POCI N/A
- ICCC N/A
- Revenue Growth
- POCI N/A
- ICCC 51.63
- 52 Week Low
- POCI $3.47
- ICCC $3.34
- 52 Week High
- POCI $6.90
- ICCC $5.82
- Technical
- Relative Strength Index (RSI)
- POCI 36.81
- ICCC 48.48
- Support Level
- POCI $4.40
- ICCC $4.56
- Resistance Level
- POCI $4.65
- ICCC $5.05
- Average True Range (ATR)
- POCI 0.24
- ICCC 0.23
- MACD
- POCI -0.03
- ICCC 0.01
- Stochastic Oscillator
- POCI 0.12
- ICCC 80.51
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.